Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2010 Dec;6(4):424-6.
doi: 10.1007/s13181-010-0079-5.

Seizure and coma following Kratom (Mitragynina speciosa Korth) exposure

Affiliations
Case Reports

Seizure and coma following Kratom (Mitragynina speciosa Korth) exposure

Jamie L Nelsen et al. J Med Toxicol. 2010 Dec.

Abstract

Reports of toxicity secondary to Kratom are rare and lack of diagnostic testing in human specimens has prevented confirmatory explanation of observed clinical effects. We present a novel case of serious human toxicity following Kratom use confirmed via quantitative analysis of urine by high performance liquid chromatography coupled to electrospray tandem mass spectrometry. A 64 year-old male was witnessed to have a seizure at home following kratom consumption. Upon arrival to the emergency department (ED), the patient was unresponsive. While in the ED, the patient sustained a second seizure. He was intubated to protect his airway. The remainder of his hospital course was uneventful. A urine specimen was collected shortly after admission and sent for analysis. The mitragynine concentration in the urine was 167 ± 15 ng/ml. We report a rare case of Kratom toxicity characterized by a seizure and coma confirmed by urinary analysis of mitragynine by high performance liquid chromatography coupled to electrospray tandem mass spectrometry. The proposed mechanism for this reaction is unclear but suggested mechanisms include adenosine binding or stimulation of adrenergic and/or serotonergic receptors similar to tramadol.

PubMed Disclaimer

References

    1. Lu S, Tran BN, Nelsen JL, Aldous KM. Quantitative analysis of mitragynine in human urine by high performance liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci [Internet] 2009;24:2499–2505. doi: 10.1016/j.jchromb.2009.06.024. - DOI - PubMed
    1. Boyer EW, Babu KM, Adkins JE, McCurdy CR, Halpern JH. Self-treatment of opioid withdrawal using kratom (Mitragynia speciosa Korth) Addiction. 2008;103(6):1048–1050. doi: 10.1111/j.1360-0443.2008.02209.x. - DOI - PMC - PubMed
    1. Roche KM, Hart K, Sangalli B, Lefberg J, Bayer M (2008) Kratom: a case of a legal high. Clin Tox 46(7):598
    1. Takayama H. Chemistry and pharmacology of analgesic indole alkaloids from the rubiaceous plant, mitragyna speciosa. Chem Pharm Bull (Tokyo) 2004;52(8):916–928. doi: 10.1248/cpb.52.916. - DOI - PubMed
    1. Matsumoto K, Mizowaki M, Suchitra T, Murakami Y, Takayama H, Sakai S, Aimi N, Watanabe H. Central antinociceptive effects of mitragynine in mice: contribution of descending noradrenergic and serotonergic systems. Eur J Pharmacol. 1996;317(1):75–81. doi: 10.1016/S0014-2999(96)00714-5. - DOI - PubMed

Publication types

MeSH terms